Trial Information
Phase I/II Study of Fractionated Stereotactic Radiotherapy for Medically Inoperable Non-Small Cell Lung Cancer (NSCLC) or Metastatic Lung Tumours
Inclusion Criteria:
- non-small cell lung cancer less than 6cm; no mediastinal or distant metastases
- Open to Alberta,Canada Residents
Exclusion Criteria:
- tumour size greater than 6cm; inadequate pulmonary function(ie. FEV1 less than 0.8
L), Karnofsky performance status less than 70, multiple co-morbid conditions
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Dose-limiting toxicity as defined by CTCAE V3 grade 4 or 5.
Principal Investigator
Harold P Lau, MD
Investigator Role:
Principal Investigator
Investigator Affiliation:
Tom Baker Cancer Center
Authority:
Canada: Health Canada
Study ID:
20131
NCT ID:
NCT00351962
Start Date:
September 2006
Completion Date:
Related Keywords:
- Lung Neoplasms
- Lung Cancer
- lung neoplasms
- metastatic lung cancer
- stereotactic radiation
- Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms